Dr Reddy’s Laboratories has launched tegoprazan, a novel patented molecule for acid-related gastrointestinal diseases, in India under the brand name PCAB. Shares of Dr Reddy’s Laboratories Ltd ended higher on Tuesday (September 16) by 0.79 % at ₹1,311.10 on the NSE.
